CDK6 Levels Regulate Quiescence Exit in Human Hematopoietic Stem Cells-Reference-Cited by-同舟云学术

CDK6 Levels Regulate Quiescence Exit in Human Hematopoietic Stem Cells

Published:2015-03 Issue:3 Volume:16 Page:302-313
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Laurenti Elisa,Frelin Catherine,Xie Stephanie,Ferrari Robin,Dunant Cyrille F.,Zandi Sasan,Neumann Andrea,Plumb Ian,Doulatov Sergei,Chen Jing,April Craig,Fan Jian-Bing,Iscove Norman,Dick John E.

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference41 articles.

1. An improved empirical bayes approach to estimating differential gene expression in microarray time-course data: BETR (Bayesian Estimation of Temporal Regulation);Aryee;BMC Bioinformatics,2009

2. Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential;Benveniste;Cell Stem Cell,2010

3. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment;Bradford;Exp. Hematol.,1997

4. The replication rate of human hematopoietic stem cells in vivo;Catlin;Blood,2011

5. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells;Cheshier;Proc. Natl. Acad. Sci. USA,1999

Cited by 268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening;Cell Stem Cell;2024-09

2. Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved;Science Immunology;2024-08-23

3. Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties;Leukemia;2024-08-21

4. Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of the cell cycle;Blood;2024-08-15

5. Comparative analysis of adverse events associated with CDK4/6 inhibitors based on FDA’s adverse event reporting system: a case control pharmacovigilance study;BMC Pharmacology and Toxicology;2024-08-09